KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Treasury Shares (2019 - 2025)

GoodRx Holdings' Treasury Shares history spans 6 years, with the latest figure at $20.0 million for Q4 2025.

  • For Q4 2025, Treasury Shares fell 10.59% year-over-year to $20.0 million; the TTM value through Dec 2025 reached $20.0 million, down 10.59%, while the annual FY2025 figure was $20.0 million, 10.59% down from the prior year.
  • Treasury Shares for Q4 2025 was $20.0 million at GoodRx Holdings, roughly flat from $20.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $22.4 million in Q4 2024 and bottomed at $939000.0 in Q3 2021.
  • The 5-year median for Treasury Shares is $6.7 million (2021), against an average of $9.3 million.
  • The largest annual shift saw Treasury Shares tumbled 86.93% in 2022 before it soared 1736.56% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $939000.0 in 2021, then soared by 800.53% to $8.5 million in 2022, then skyrocketed by 41.91% to $12.0 million in 2023, then skyrocketed by 86.41% to $22.4 million in 2024, then dropped by 10.59% to $20.0 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Treasury Shares are $20.0 million (Q4 2025), $20.0 million (Q3 2025), and $20.0 million (Q2 2025).